[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642324":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":34,"centralContacts":39,"locations":48,"responsibleParty":66,"collaborators":68,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":9,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":24,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":97,"whyStopped":24,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Wooshin Labottach Co., Ltd.","INDUSTRY",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexpanthenol","EXPERIMENTAL","On the wound will be applied an experimental Hydrogel plaster with Dexpanthenol",[13],"Device: hydrogel plaster with dexpanthenol",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard plaster","ACTIVE_COMPARATOR","On the wound will be applied a standard plaster, with no active ingredients",[19],"Device: Standard plaster",{"label":21,"type":22,"description":23,"interventionNames":24},"No treatment","NO_INTERVENTION","The wound is not covered or medicated",null,[26,31],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":24},"DEVICE","hydrogel plaster with dexpanthenol","On the wound will be applied daily an hydrogel plaster with Dexpanthenol",[9],{"type":27,"name":15,"description":32,"armGroupLabels":33,"otherNames":24},"On the wound will be daily applicated a standard plaster on the market",[15],[35],{"name":36,"affiliation":37,"role":38},"Alessandro Guzzo, MD","la U.O.C. Anestesia Rianimazione degli Ospedali Riuniti Padova Sud con indirizzo via Albere, 30 Monselice","PRINCIPAL_INVESTIGATOR",[40,44],{"name":36,"role":41,"phone":42,"phoneExt":24,"email":43},"CONTACT","+39 0429715610","alessandro.guzzo@aulss6.veneto.it",{"name":45,"role":41,"phone":46,"phoneExt":24,"email":47},"Adolfo Gasparetto, MD","+39 3356641965","adolfogasparetto@nextrasearch.it",[49],{"facility":50,"status":24,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"la U.O.C. Anestesia Rianimazione degli Ospedali Riuniti Padova Sud","Monselice","PD","35043","Italy","IT",{"type":57,"coordinates":58},"Point",[59,60],11.74984,45.239,{"lat":60,"lon":59},[63,65],{"name":36,"role":41,"phone":64,"phoneExt":24,"email":43},"+39 0429714111",{"name":36,"role":38,"phone":24,"phoneExt":24,"email":24},{"type":67,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[69],{"name":70,"class":71},"Nextrasearch S.r.l.s.","OTHER","100642324","a-study-to-evaluate-the-safety-and-clinical-performance-of-a-dexpanthenol-medicated-hydrogel-patch-in-the-treatment-of-standardized-superficial-abrasions-100642324",false,"NCT07642973","A Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions","A Randomized, Single-Blind, Intra-Individual Controlled Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions","Inclusion Criteria:\n\n* Healthy male or female volunteers aged 18 to 64 years (inclusive).\n* Informed consent form signed voluntarily before any study-related procedure.\n* Subjects willing and able to comply with all study protocol requirements, including scheduled visits and home-wear restrictions.\n* Intact, healthy skin on both volar forearms (free of tattoos, scars, sunburns, or active skin lesions in the designated test areas).\n* Agree to take precautions to prevent pregnancy (applicable only to non-menopausal women), including abstinence, intrauterine devices (IUDs), progestogen implants, combined estrogenic-progestogen contraceptives, the use of condoms;\n\nExclusion Criteria:\n\n* Known hypersensitivity or allergy to Dexpanthenol, hydrogel components, acrylic adhesives, or any component of the investigational devices.\n* History of keloid formation, hypertrophic scarring, or abnormal wound healing.\n* Active dermatological conditions (e.g., psoriasis, eczema, atopic dermatitis, active infections) on the upper extremities.\n* History of diabetes mellitus, peripheral vascular disease, or arterial\u002Fvenous microangiopathy.\n* Systemic treatment with corticosteroids, immunosuppressive drugs, Anticoagulants, antiplatelet agents or cytostatic agents within 4 weeks prior to Baseline, or anticipated need during the study.\n* Topical treatment (steroids, retinoids, antibiotics, or moisturizers) applied to the volar forearms within 2 weeks prior to Baseline.\n* Active heavy smokers (more than 10 cigarettes per day) or users of nicotine-replacement therapies (nicotine alters cutaneous microcirculation and significantly impairs wound healing kinetics)\n* Pregnant or lactating women, or women of childbearing potential not using highly effective contraception (see inclusion criteria).\n* Not willing and able to comply with all study protocol requirements",true,"ALL","18 Years","64 Years",{"count":84,"type":85},40,"ESTIMATED","INTERVENTIONAL",[88],"NA","Clinical evaluation of a Dexpanthenol-medicated wound plaster on standardized superficial skin abrasions",[91,92],"Skin Wounds","Abrasion",[94,95,96],"superficial wounds","dexpanthenol","plaster","NOT_YET_RECRUITING","2026-06-12",{"date":100,"type":101},"2026-06-16","ACTUAL",{"date":103,"type":85},"2026-09",{"date":105,"type":85},"2026-12",{"name":5,"class":6},1]